Tekmira Reports on Voting Results From 2014 Annual Meeting of Shareholders

[GlobeNewswire] – VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference (RNAi) therapeutics, announced the voting results from its Annual General and Special Meeting … more

View todays social media effects on TKMR

View the latest stocks trending across Twitter. Click to view dashboard

See who Tekmira is hiring next, click here to view